<SEC-DOCUMENT>0001193125-25-165170.txt : 20250725
<SEC-HEADER>0001193125-25-165170.hdr.sgml : 20250725
<ACCEPTANCE-DATETIME>20250725122339
ACCESSION NUMBER:		0001193125-25-165170
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250725
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250725
DATE AS OF CHANGE:		20250725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ikena Oncology, Inc.
		CENTRAL INDEX KEY:			0001835579
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40287
		FILM NUMBER:		251150444

	BUSINESS ADDRESS:	
		STREET 1:		50 NORTHERN AVE.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		857-343-8292

	MAIL ADDRESS:	
		STREET 1:		50 NORTHERN AVE.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d62567d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ima="http://www.ikenaoncology.com/20250725" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-07-25_to_2025-07-25">IKENA ONCOLOGY, INC.</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2025-07-25_to_2025-07-25">NASDAQ</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2025-07-25_to_2025-07-25" name="dei:EntityCentralIndexKey" contextRef="duration_2025-07-25_to_2025-07-25">0001835579</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2025-07-25_to_2025-07-25" name="dei:AmendmentFlag" contextRef="duration_2025-07-25_to_2025-07-25">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="ima-20250725.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-07-25_to_2025-07-25"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835579</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-07-25</xbrli:startDate> <xbrli:endDate>2025-07-25</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835579</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-07-25</xbrli:startDate> <xbrli:endDate>2025-07-25</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_1">8-K</ix:nonNumeric></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt:date-monthname-day-year-en" id="Fact_0">July 25, 2025</ix:nonNumeric></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName" id="Fact_21">IMAGENEBIO, INC.</span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:stateprovnameen" id="Fact_6">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_7">001-40287</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_8">81-1697316</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_30">12526 High Bluff Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_31">Suite 345</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_26">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:stateprovnameen" id="Fact_27">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_25">92130</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_29">617</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_28">901-7098</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityInformationFormerLegalOrRegisteredName" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_2">Ikena Oncology, Inc.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_3">645 Summer Street</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_4">Suite 101</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" id="Fact_5">Boston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember" format="ixt-sec:stateprovnameen" id="Fact_33">Massachusetts</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:boolballotbox" id="Fact_10">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:boolballotbox" id="Fact_12">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:boolballotbox" id="Fact_14">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:boolballotbox" id="Fact_16">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_22">Common Stock, $0.001 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_23">IMA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName" id="Fact_24">The Nasdaq Capital Market</span></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:boolballotbox" id="Fact_18">&#9746;</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2025-07-25_to_2025-07-25" format="ixt-sec:boolballotbox" id="Fact_20">&#9744;</ix:nonNumeric></p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Introductory Note</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;25, 2025, the Delaware corporation formerly known as &#8220;Ikena Oncology, Inc.&#8221; completed its previously announced merger with Inmagene Biopharmaceuticals, an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Inmagene</span></span>&#8221;), in accordance with the terms of the Agreement and Plan of Merger, dated as of December&#160;23, 2024, by and among Ikena Oncology, Inc. (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Ikena</span></span>&#8221;), Insight Merger Sub I, an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands and a direct, wholly owned subsidiary of Ikena (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Merger Sub I</span></span>&#8221;), Insight Merger Sub II, an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands and a direct, wholly owned subsidiary of Ikena (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Merger Sub II</span></span>&#8221;), and Inmagene, providing for the merger of Merger Sub I with and into Inmagene, with Inmagene surviving as a wholly owned subsidiary of Ikena (such transaction, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">First Merger</span></span>&#8221;), and the subsequent merger of the surviving entity of the First Merger with and into Insight Merger Sub II, with Merger Sub II surviving as a wholly owned subsidiary of Ikena (collectively with the First Merger, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Merger</span></span>&#8221;).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also on July&#160;25, 2025, Ikena changed its name from &#8220;Ikena Oncology, Inc.&#8221; to &#8220;ImageneBio, Inc.&#8221; (together with its subsidiaries, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221;).</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;7.01 Regulation FD Disclosure.</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;25, 2025, the Company issued a press release announcing the completion of the Merger and others matters relating thereto. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d62567dex991.htm">Press Release, dated as of July&#160;25, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table><p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">
<tr>
<td style="width:45%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>
<td style="vertical-align:bottom"/>
<td style="width:3%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">IMAGENEBIO, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;25, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kristin Yarema, Ph.D.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Kristin Yarema, Ph.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d62567dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g62567dsp1a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g62567dsp1.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private
Placement of $75 Million </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The combined company will operate under the name &#147;ImageneBio, Inc.&#148; and will begin trading on
Nasdaq under the ticker symbol &#147;IMA&#148; at market open on Monday, July&nbsp;28, 2025 </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>ImageneBio, Inc. will continue to drive
the ongoing Phase 2b clinical trial of <FONT STYLE="white-space:nowrap">non-depleting</FONT> anti-OX40 monoclonal antibody, <FONT STYLE="white-space:nowrap">IMG-007,</FONT> in patients with <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> atopic dermatitis </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Phase 2b topline readout for <FONT
STYLE="white-space:nowrap">IMG-007</FONT> in atopic dermatitis expected in the fourth quarter of 2026 </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SAN DIEGO, CA, July&nbsp;25, 2025 &#151;
Inmagene Biopharmaceuticals (&#147;Inmagene&#148;), a clinical stage biotechnology company dedicated to developing disease-modifying treatments for immunological/autoimmune and inflammatory (&#147;I&amp;I&#148;) diseases, today announced the
completion of its previously announced merger&nbsp;with Ikena Oncology, Inc. (Nasdaq: IKNA) (&#147;Ikena&#148;). The combined company will operate under the name ImageneBio, Inc. (&#147;ImageneBio&#148;) and will trade on The Nasdaq Capital Market
(&#147;Nasdaq&#148;) under the ticker symbol &#147;IMA&#148; beginning at market open on July&nbsp;28, 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrent with the closing of the merger,
Inmagene and Ikena completed a&nbsp;$75.0 million&nbsp;private placement with a syndicate of existing and new investors including Deep Track Capital, Foresite Capital, RTW Investments, and existing Ikena investors such as BVF Partners L.P., Blue Owl
Healthcare Opportunities, Omega Funds, and OrbiMed. The combined company will be led by Kristin Yarema, Ph.D. as its Chief Executive Officer, as announced earlier this week. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are pleased with the outcome of this transaction and are well-positioned to advance <FONT STYLE="white-space:nowrap">IMG-007</FONT> into late-stage
development. OX40 inhibition is a promising approach that may have the potential to treat a broad range of immunological and inflammatory diseases where patients continue to wait for more and novel treatment options. We are excited about the
emerging profile of <FONT STYLE="white-space:nowrap">IMG-007,</FONT> which we believe will prove to be differentiated, and we look forward to executing our development plan in atopic dermatitis and potentially initiating studies in additional
indications,&#148; commented Dr.&nbsp;Kristin Yarema. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, in connection with the completion of the transaction and as recently approved by
Ikena&#146;s shareholders, Ikena implemented a reverse split of its common stock at a ratio of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-12</FONT></FONT> shares. Following the reverse stock split and based on the final
exchange ratio of approximately 0.003051 shares of Ikena common stock for each Inmagene share, immediately following the closing of the merger, the legacy equity holders of Inmagene owned approximately 55.0% of the combined company&#146;s
outstanding common stock and the legacy equity holders of Ikena owned approximately 45.0% of the combined company&#146;s outstanding common stock, in each case, on a fully diluted basis. Following the consummation of the concurrent private
placement, the legacy equity holders of Inmagene owned approximately 43.1% of the combined company&#146;s outstanding common stock, the legacy equity holders of Ikena owned approximately 35.3% of the combined company&#146;s outstanding common stock,
and the investors in the concurrent financing owned approximately 21.6% of the combined company&#146;s outstanding common stock, in each case, on a fully diluted basis. Following the reverse stock split, the closing of both the merger and concurrent
financing, ImageneBio will have approximately 11.6&nbsp;million shares of common stock outstanding. ImageneBio&#146;s shares are expected to begin trading on Nasdaq at market open on July&nbsp;28, 2025 under the ticker symbol &#147;IMA&#148; and new
CUSIP number, 45175G 207. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g62567dsp1a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g62567dsp1.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP served as legal counsel to Ikena, and Cooley LLP served as legal counsel to Inmagene. Leerink Partners LLC served as exclusive financial
advisor to Ikena. Evercore served as exclusive financial advisor to Inmagene. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ImageneBio, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ImageneBio is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous
immunological/autoimmune and inflammatory (&#147;I&amp;I&#148;) diseases. Imagene&#146;s purpose is to globally develop new medicines with differentiated profiles that can effectively control and change the course of I&amp;I diseases for affected
patients, treat their symptoms, and improve quality of life. The company&#146;s lead asset <FONT STYLE="white-space:nowrap">IMG-007,</FONT> a nondepleting anti-OX40 monoclonal antibody, recently completed Phase 2a clinical trials in atopic
dermatitis and alopecia areata. ImageneBio is currently conducting a Phase 2b clinical trial of <FONT STYLE="white-space:nowrap">IMG-007</FONT> in patients with
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> atopic dermatitis. For more information, please visit www.inmagenebio.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About <FONT STYLE="white-space:nowrap">IMG-007</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">IMG-007</FONT> is an investigational, <FONT STYLE="white-space:nowrap">non-depleting</FONT> monoclonal antibody targeting OX40, a receptor protein primarily found on activated human T cells. When OX40 binds its ligand
OX40L in human tissue, the signal generated plays a key role in the activation, expansion, and survival for many subtypes of T cells. Targeted inhibition of OX40 is thus an emerging potential therapeutic strategy to treat a wide range of I&amp;I
diseases where aberrant signaling of one or more T cell subtypes is believed to drive disease. <FONT STYLE="white-space:nowrap">IMG-007</FONT> has been engineered to include a silenced antibody-dependent cell-mediated cytotoxicity function to avoid
T cell depletion or killing, to minimize safety risk. This technology also resulted in extended half-life to prolong therapeutic activity with the aim of maximizing time between doses for a patient. In Phase 2a trials in patients with <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> atopic dermatitis and severe alopecia areata, <FONT STYLE="white-space:nowrap">IMG-007</FONT> exhibited sustained clinical and pharmacodynamic activity and
was well tolerated. <FONT STYLE="white-space:nowrap">IMG-007</FONT> was originally discovered by HUTCHMED. Clinical development is ongoing: additional information about the ongoing Phase 2b trial in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> atopic dermatitis is available at&nbsp;www.clinicaltrials.gov&nbsp;using identifier:&nbsp;NCT07037901. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
&#147;forward-looking statements&#148; within the meaning of the &#147;safe harbor&#148; provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, express or implied statements regarding the anticipated
benefits of the merger; the expected trading of the combined company&#146;s stock on Nasdaq under the ticker symbol &#147;IMA&#148; and on a post-reverse stock split basis; the future operations of the combined company; the nature, strategy and
focus of the combined company; the development and commercial potential and potential value and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g62567dsp1a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g62567dsp1.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
benefits of <FONT STYLE="white-space:nowrap">IMG-007;</FONT> planned or anticipated preclinical and clinical drug development activities and related timelines, including the expected timing for
data and other clinical results and the potential initiation of studies in additional indications; the expected leadership of the combined company; the potential to receive and distribute any proceeds pursuant to the contingent value rights
agreement of Ikena and contingent value rights agreement of Inmagene; and other statements regarding management&#146;s intentions, plans, beliefs, expectations or forecasts for the future. All statements other than statements of historical fact
contained in this press release are forward-looking statements. These forward-looking statements are made as of the date they were first issued, and were based on the then-current expectations, estimates, forecasts, and projections, as well as the
beliefs and assumptions of management of each of Inmagene and Ikena. There can be no assurance that future developments affecting the combined company or any future transactions or distributions described herein will be those that have been
anticipated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are
beyond ImageneBio&#146;s control. ImageneBio&#146;s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: risks associated with the possible
failure to realize certain anticipated benefits of the merger, including with respect to future financial and operating results; potential litigation relating to the transaction that could be instituted against the combined company or its directors;
risks related to the commencement of shares to begin trading on Nasdaq; the uncertainties associated with the combined company&#146;s current and future product candidates, as well as risks associated with the clinical development and regulatory
approval of product candidates, including potential delays in the completion of clinical trials and potential safety and other complications thereof; the significant net losses that the combined company has incurred since inception; the combined
company&#146;s ability to initiate and complete ongoing and planned preclinical studies and clinical trials and advance its product candidates through clinical development; the timing of the availability of data from the combined company&#146;s
clinical trials; the outcome of preclinical testing and clinical trials of the combined company&#146;s product candidates, including the ability of those trials to satisfy relevant governmental or regulatory requirements; <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> and clinical results may not be indicative of results that may be observed in the future; the combined company&#146;s plans to research, develop and commercialize
<FONT STYLE="white-space:nowrap">IMG-007</FONT> or its future product candidates; the clinical utility, potential benefits and market acceptance of the combined company&#146;s product candidates; the requirement for additional capital to continue to
advance these product candidates, which may not be available on favorable terms or at all; the combined company&#146;s ability to attract, hire, and retain skilled executive officers and employees; the combined company&#146;s ability to protect its
intellectual property and proprietary technologies; the combined company&#146;s reliance on third parties, contract manufacturers, and contract research organizations; the possibility that the combined company may be adversely affected by other
economic, political, business, or competitive factors; risks associated with changes in applicable laws or regulations or government resources and policies; and the possibility that contingent value rights holders of legacy Ikena and contingent
value rights holders of legacy Inmagene may never receive any proceeds pursuant to the Ikena contingent value rights agreement and Inmagene contingent value rights agreement. Actual results and the timing of events could differ materially from those
anticipated in such forward-looking statements as a result of these risks and uncertainties. These and other risks and uncertainties are more fully described in Ikena&#146;s periodic filings with the Securities and Exchange Commission (the
&#147;SEC&#148;), including the factors described in the section titled &#147;Risk Factors&#148; in Ikena&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended June&nbsp;30, 2025, filed with the SEC on
July&nbsp;24, 2025, as well as the Form <FONT STYLE="white-space:nowrap">S-4,</FONT> as amended (File No.&nbsp;333- 285881), initially filed by Ikena with the SEC on March&nbsp;18, 2025, and declared effective on June&nbsp;11, 2025 and other
documents subsequently filed with or furnished by the combined company to the SEC. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g62567dsp1a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g62567dsp1.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should not place undue reliance on these forward-looking statements, which are made only as of the date
hereof or as of the dates indicated in the forward-looking statements. Except as may be required under applicable law, ImageneBio expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. This press release does not purport to summarize all of the
conditions, risks and other attributes of an investment in the combined company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ImageneBio Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anna Vardanyan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">vardanyana@inmagenebio.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian Ritchie </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">britchie@lifesciadvisors.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ima-20250725.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/25/2025 5:47:54 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:ima="http://www.ikenaoncology.com/20250725"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:us-types="http://fasb.org/us-types/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.ikenaoncology.com/20250725"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ima-20250725_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ima-20250725_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ima-20250725_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="ima_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="ima_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>ima-20250725_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/25/2025 5:47:55 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ima-20250725.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="ima-20250725.xsd#ima_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="ima_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="ima-20250725.xsd#ima_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="ima_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember" xlink:type="locator" xlink:label="dei_FormerAddressMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="ima_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ima_DocumentAndEntityInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0.01" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_2" order="23.0001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_FormerAddressMember" order="24" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="33.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="36.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="37.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="38.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="39.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="44.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="46.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="47.001" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ima-20250725_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/25/2025 5:47:54 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="ima-20250725.xsd#ima_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="ima_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ima_DocumentAndEntityInformationTable" xlink:to="ima_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="ima_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="ima_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="ima-20250725.xsd#ima_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="ima_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="ima_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="ima_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="ima_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AddressTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Address Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AddressTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Address Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Addresses Address Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Addresses Address Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember" xlink:type="locator" xlink:label="dei_FormerAddressMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_FormerAddressMember" xlink:to="dei_FormerAddressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_FormerAddressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Former Address [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_FormerAddressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Former Address [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 2</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information Former Legal Or Registered Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Information Former Legal Or Registered Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ima-20250725_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 7/25/2025 5:47:53 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ima-20250725.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="ima-20250725.xsd#ima_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="ima_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="ima_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="ima-20250725.xsd#ima_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="ima_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationTable" xlink:to="ima_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0.01" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember" xlink:type="locator" xlink:label="dei_FormerAddressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain" xlink:to="dei_FormerAddressMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ima_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g62567dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g62567dsp1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( !L ? ,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /WYEEC@CDFFD2&&%'EEEE=8XXHXU+/)([$*B*H)+$@  D\"
ME*481<I-1C%-MMV22U;;>B26[Z%0A*<HTZ<7*<FHQC%-R<F[))+5MO1):MZ(
M\<\2_$YFAOK7P>87NH;?4[6/4M2LKC[(^JO8^([314TN S0MJ.WQ)H]K',)/
M)AEMKR*2WF=;A)!QX''0QN983#T*4JF#5:V)JM2IKV4%7Y_83:=Y1E1LY2CR
M<DX3@YJ43UL=E$\NRK&8O&58T<;[&,L+0A*%2:J2GA.7ZU!/W(RI8J\(0FZJ
MK4JE*M"E*G)'I/AS6[#7M*MKRQU&#4]L<45S<0V\MD3<B)&:1]/N#YUBLRLL
M\4<N=T,\4B,\<B.^U#%8;&0=7"SYJ5VDG=2CU49QE&,D^5IJ\8\T6II<LDWQ
M8S 8S+:JP^-I>RK**=TXRA+HY0G"4Z<DI*4)<DY<DXRIR:G"26[6YR!0 4 %
M !0 4 % !0 4 % !0 4 % 'G'Q3O)[3PL(897@2_U33[&ZG25K<Q6;.]S,#=
MK>VXM%E%JL!>1;J)A/Y4MK/'*R5Y&=3E#!PIJ3A&O6I4YR3<;0;<I>\IPY>;
MEY+OGB^;EE3G&31]#PS2A+,9U7!5)X3#UZU*#BIWJJ*A#]VZ57VCASNHHQ]C
M./)[2%>E.$9'DOPX\'+XDT'Q7KLVL&QO+B/5_#.DQVR6CV7ARVMK6"V6]B4P
MJ%NC:!(XVB\B.&S:..V2&/RUA^D@\/@\/@,/0PT'2C"G4EI;VEU94URV2IQ2
M45%*VEK65CYO%U,5BL7CZU;$5(U54J0C=M\C4N9U)<UVZDI-SE*3<FY.3DY-
MR;_@CJ]Y/JD*NZL-6T2ZN-1BMY1)#]LTZ>P2UU"2"*YA6TFFM[N2)I9[6\EE
MCBM(8[BWM;."U3Y^K3IX/B/%8?#:4:U.<IQ72=.5/EFXJ<5&3C-PE.5.<YJ-
M./M(0IQ@_J)SJ8WA/!XK%*U?"UJ4*<Y*S=.M"LZE.,I4I.4(SI1J1IPK4:5*
M4ZU1T:E6O4JKY8\/Z[\:OB&?@]HGA7XJ^(-"\4&R_::\86%S?WDEYI'B/6_
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+0 4 % !0 4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g62567dsp1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g62567dsp1a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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.@;>0?T_2C] V\@H _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ima_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 25,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IKENA ONCOLOGY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-1697316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">12526 High Bluff Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">901-7098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information Former Legal Or Registered Name</a></td>
<td class="text">Ikena Oncology, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001835579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ima_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">645 Summer Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ima_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ima_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ima_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d62567d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d62567d8k.htm">d62567d8k.htm</File>
    <File>ima-20250725.xsd</File>
    <File>ima-20250725_def.xml</File>
    <File>ima-20250725_lab.xml</File>
    <File>ima-20250725_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d62567d8k.htm": {
   "nsprefix": "ima",
   "nsuri": "http://www.ikenaoncology.com/20250725",
   "dts": {
    "inline": {
     "local": [
      "d62567d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "ima-20250725.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ima-20250725_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ima-20250725_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ima-20250725_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 29
   },
   "report": {
    "R1": {
     "role": "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-07-25_to_2025-07-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d62567d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-07-25_to_2025-07-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d62567d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ima_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ikenaoncology.com/20250725",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ima_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ikenaoncology.com/20250725",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "terseLabel": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses Address Type [Axis]",
        "terseLabel": "Entity Addresses Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information Former Legal Or Registered Name",
        "terseLabel": "Entity Information Former Legal Or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "terseLabel": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ikenaoncology.com//20250725/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-25-165170-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-165170-xbrl.zip
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M=6.NF)(+//VI>I[X3^>9OZIW_O]02P,$%     @ \F+Y6M OQB3J%   ?4P
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MD8)&@0NLK%CQC@F%UL+3C%7&7 $!5M]Q?V3,+1UA)C.6I+(J2Q!29J(A#L*
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MR[TCT3SJDE@%$K\X^A47^7\[]G]02P,$%     @ \F+Y6F=?8"=Z P  Q0P
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M56RA5JKFE4T$X"KDLIA:Z9A$![U=<58Q3N9QC:P]3_OF>/=R"4M,;T2\[(&
MH/J26=9FK7+^$D3I$]HI#\,-2\)UZ4WY 7"M!.\Y);X^6[+EE9ZG@F!:EET1
MLE9JMP*,=-!1(]HHFH.NN%DLRH_5ERPT274JY0;$UQ,NL%/ORP=_H\?8KM>?
MSX@J=Q0OQM5*:R:PR;W?[\(Y+ST<]T"-^.E\ZZ\P6T*5X%.,;2!FGNN0MM0>
M^"#XHUKI8;3&;%<M1!XPT039K7Y?3$9)K?BD59%I ;X!FJ=Z$@I,IWH";O^
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M=-NF$!*J3\J@I-V?UX9?Z,JSVIJKK6XXEZ_4<ZW+3;1XNK/<\C]02P,$%
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M#   $               @ &3)@  :6UA+3(P,C4P-S(U+GAS9%!+ 0(4 Q0
M   ( /)B^5H_*VK-PP4  +TW   4              "  3LJ  !I;6$M,C R
M-3 W,C5?9&5F+GAM;%!+ 0(4 Q0    ( /)B^5JEN>L*UP<   I<   4
M          "  3 P  !I;6$M,C R-3 W,C5?;&%B+GAM;%!+ 0(4 Q0    (
M /)B^5IF ]:@:@4  "H[   4              "  3DX  !I;6$M,C R-3 W
@,C5?<')E+GAM;%!+!08     !@ & 'T!  #5/0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d62567d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ima-20250725.xsd" xlink:type="simple"/>
    <context id="duration_2025-07-25_to_2025-07-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835579</identifier>
        </entity>
        <period>
            <startDate>2025-07-25</startDate>
            <endDate>2025-07-25</endDate>
        </period>
    </context>
    <context id="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835579</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-25</startDate>
            <endDate>2025-07-25</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-07-25_to_2025-07-25"
      id="Hidden_dei_EntityRegistrantName">IKENA ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:SecurityExchangeName
      contextRef="duration_2025-07-25_to_2025-07-25"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-07-25_to_2025-07-25"
      id="Hidden_dei_EntityCentralIndexKey_duration_2025-07-25_to_2025-07-25">0001835579</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2025-07-25_to_2025-07-25"
      id="Hidden_dei_AmendmentFlag_duration_2025-07-25_to_2025-07-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_0">2025-07-25</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_7">001-40287</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_8">81-1697316</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_30">12526 High Bluff Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_31">Suite 345</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_26">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_27">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_25">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_29">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_28">901-7098</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_2">Ikena Oncology, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:EntityAddressAddressLine1
      contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_3">645 Summer Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_4">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_5">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="duration_2025-07-25_to_2025-07-25_dei-EntityAddressesAddressTypeAxis_dei-FormerAddressMember"
      id="Fact_33">MA</dei:EntityAddressStateOrProvince>
    <dei:WrittenCommunications contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_12">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_22">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_23">IMA</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_18">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2025-07-25_to_2025-07-25" id="Fact_20">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
